Pulmonary Surfactant(PS) Therapy at High Altitude Area
A Multicenter Study of Pulmonary Surfactant(PS) Therapy in the Treatment of Neonatal Acute Respiratory Distress Syndrome(RDS) at High Altitude Area
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Listed as NCT03440333, this observational or N/A phase trial focuses on NRDS and Surfactant and remains completed. Sponsored by Daping Hospital and the Research Institute of Surgery of the Third Military Medical University, it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Apr 2019 — Jan 2021 [monthly]
Completed
-
Dec 2018 — Apr 2019 [monthly]
Completed
▶ Show 3 earlier versions
-
Jun 2018 — Dec 2018 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Completed NA
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Shannan People's Hospital
- Women and Children Hospital of Qinghai Province
- the first people hospital of Lasa
- the first people hospital of Shigatse
- the first people hospital of Tibet autonomous region
- the people hospital of Ali
- the people hospital of Changdu
- the people hospital of Laqu
- the people hospital of Linzhi
- the second people hospital of Lasa
- the second people hospital of Tibet autonomous region
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.